Adjunctive azetukalner cut monthly focal onset seizure frequency by 53% in phase III study ...

The study sought to evaluate the efficacy, safety, and tolerability of azetukalner, administered as an oral, adjunctive, once ...

A growing body of neuroscience research is converging on a counterintuitive idea: the disorderly brain activity triggered by LSD might actually work against the hyper-synchronized neural firing that ...

Xenon Pharmaceuticals’ bull case improved after X-TOLE2 showed robust focal seizure reduction in a highly refractory patient ...

Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time pointsX-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in monthl ...

(from left) Prof. Florian Mormann and Dr. Stefanie Liebe revise an established theory of stimulus processing in nerve cells during memory processing. How does the brain retain a sequence of events in ...

This valuable study addressed a key question in epilepsy research: whether the recordings of very fast oscillations in the brain (>250Hz, fast ripples) reflect underlying pathology or might be a ...

Neuronal degeneration is the most severe long-term consequence of repetitive seizures in patients with epilepsy, which until now was thought to be primarily caused by excitotoxicity, or ...

Fragile X syndrome (FXS) is an inherited genetic developmental condition that strongly impacts brain development. Despite the ...